Pamicogrel

CAS No. 101001-34-7

Pamicogrel( KBT3022 )

Catalog No. M22618 CAS No. 101001-34-7

Pamicogrel is an inhibitor of COX. Pamicogrel has platelet anti-aggregatory properties which is under development by Kanebo for chronic arterial occlusion.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 31 In Stock
5MG 50 In Stock
10MG 80 In Stock
25MG 149 In Stock
50MG 258 In Stock
100MG 417 In Stock
200MG 601 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Pamicogrel
  • Note
    Research use only, not for human use.
  • Brief Description
    Pamicogrel is an inhibitor of COX. Pamicogrel has platelet anti-aggregatory properties which is under development by Kanebo for chronic arterial occlusion.
  • Description
    Pamicogrel is an inhibitor of COX. Pamicogrel has platelet anti-aggregatory properties which is under development by Kanebo for chronic arterial occlusion. Pamicogrel also has potential in both prophylaxis and treatment of ischemic brain injury.
  • In Vitro
    Pamicogrel is a cyclooxygenase inhibitor with platelet anti-aggregatory properties which is under development by Kanebo for chronic arterial occlusion. Pamicogrel also has potential in both prophylaxis and treatment of ischemic brain injury.
  • In Vivo
    ——
  • Synonyms
    KBT3022
  • Pathway
    Chromatin/Epigenetic
  • Target
    COX
  • Recptor
    COX
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    101001-34-7
  • Formula Weight
    448.53
  • Molecular Formula
    C25H24N2O4S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:82 mg/mL (182.82 mM; Need ultrasonic)
  • SMILES
    CCOC(=O)Cn1cccc1-c1nc(c(s1)-c1ccc(OC)cc1)-c1ccc(OC)cc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Light P. Pamicogrel (Kanebo). IDrugs. 1999 Sep;2(9):938-42.
molnova catalog
related products
  • Sasapyrine

    Salsalate is a nonsteroidal anti-inflammatory agent for oral administration. Salsalate's mode of action as an anti-inflammatory and antirheumatic agent may be due to inhibition of synthesis and release of prostaglandins.

  • FPL 62064

    FPL 62064 is a potent ?dual inhibitor of 5-lipoxygenase (5-LOX) and COX (IC50 of 3.5 μM and 3.1 μM for RBL-1 cytosolic 5-lipoxygenase and prostaglandin synthetase respectively).?

  • Parecoxib

    A potent and selective COX-2 inhibitor; a water-soluble prodrug of valdecoxib.